<?xml version="1.0" encoding="UTF-8" ?><!-- Generated on Sat, 12 Sep 2026 19:58:14 -0400--><rss version="2.0">
    <channel>
        <title>Skye Bioscience, Inc. (SKYE) SEC Filings</title>
        <link>https://ir.skyebioscience.com/sec-filings/all-sec-filings/rss</link>
        <description>Skye Bioscience, Inc. (SKYE) - All SEC Filings</description>
        <language>en-us</language>
                                            <image>
                <url>https://d1io3yog0oux5.cloudfront.net/_e076ea37d6bf897725c32eff044cb88a/skyebioscience/files/theme/images/logo-sm.png</url>
                <title>Skye Bioscience, Inc. Logo</title>
                <link></link>
            </image>
                <generator>Equisolve Investor Relations Suite</generator>
        
                            <item>
                <title><![CDATA[DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material]]></title>
                <description><![CDATA[DEFA14A]]></description>
                <link>https://ir.skyebioscience.comhttps://ir.skyebioscience.com/sec-filings/all-sec-filings/content/0001628280-26-061564/0001628280-26-061564.pdf</link>
                <pubDate>Fri, 11 Sep 26 00:00:00 -0400</pubDate>
                <guid>https://ir.skyebioscience.comhttps://ir.skyebioscience.com/sec-filings/all-sec-filings/content/0001628280-26-061564/0001628280-26-061564.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[8-K - Current report]]></title>
                <description><![CDATA[8-K]]></description>
                <link>https://ir.skyebioscience.comhttps://ir.skyebioscience.com/sec-filings/all-sec-filings/content/0001628280-26-061558/0001628280-26-061558.pdf</link>
                <pubDate>Fri, 11 Sep 26 00:00:00 -0400</pubDate>
                <guid>https://ir.skyebioscience.comhttps://ir.skyebioscience.com/sec-filings/all-sec-filings/content/0001628280-26-061558/0001628280-26-061558.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material]]></title>
                <description><![CDATA[2 Related Documents: DEFA14A, EX-10.1]]></description>
                <link>https://ir.skyebioscience.comhttps://ir.skyebioscience.com/sec-filings/all-sec-filings/content/0001628280-26-058615/0001628280-26-058615.pdf</link>
                <pubDate>Mon, 24 Aug 26 00:00:00 -0400</pubDate>
                <guid>https://ir.skyebioscience.comhttps://ir.skyebioscience.com/sec-filings/all-sec-filings/content/0001628280-26-058615/0001628280-26-058615.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[8-K - Current report]]></title>
                <description><![CDATA[2 Related Documents: 8-K, EX-10.1]]></description>
                <link>https://ir.skyebioscience.comhttps://ir.skyebioscience.com/sec-filings/all-sec-filings/content/0001628280-26-058605/0001628280-26-058605.pdf</link>
                <pubDate>Mon, 24 Aug 26 00:00:00 -0400</pubDate>
                <guid>https://ir.skyebioscience.comhttps://ir.skyebioscience.com/sec-filings/all-sec-filings/content/0001628280-26-058605/0001628280-26-058605.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[4 - Statement of changes in beneficial ownership of securities]]></title>
                <description><![CDATA[4]]></description>
                <link>https://ir.skyebioscience.comhttps://ir.skyebioscience.com/sec-filings/all-sec-filings/content/0001598549-26-000005/0001598549-26-000005.pdf</link>
                <pubDate>Thu, 20 Aug 26 00:00:00 -0400</pubDate>
                <guid>https://ir.skyebioscience.comhttps://ir.skyebioscience.com/sec-filings/all-sec-filings/content/0001598549-26-000005/0001598549-26-000005.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[4 - Statement of changes in beneficial ownership of securities]]></title>
                <description><![CDATA[4]]></description>
                <link>https://ir.skyebioscience.comhttps://ir.skyebioscience.com/sec-filings/all-sec-filings/content/0001231919-26-000959/0001231919-26-000959.pdf</link>
                <pubDate>Thu, 20 Aug 26 00:00:00 -0400</pubDate>
                <guid>https://ir.skyebioscience.comhttps://ir.skyebioscience.com/sec-filings/all-sec-filings/content/0001231919-26-000959/0001231919-26-000959.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[8-K/A - Current report]]></title>
                <description><![CDATA[8-K/A]]></description>
                <link>https://ir.skyebioscience.comhttps://ir.skyebioscience.com/sec-filings/all-sec-filings/content/0001628280-26-058120/0001628280-26-058120.pdf</link>
                <pubDate>Thu, 20 Aug 26 00:00:00 -0400</pubDate>
                <guid>https://ir.skyebioscience.comhttps://ir.skyebioscience.com/sec-filings/all-sec-filings/content/0001628280-26-058120/0001628280-26-058120.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material]]></title>
                <description><![CDATA[DEFA14A]]></description>
                <link>https://ir.skyebioscience.comhttps://ir.skyebioscience.com/sec-filings/all-sec-filings/content/0001628280-26-058121/0001628280-26-058121.pdf</link>
                <pubDate>Thu, 20 Aug 26 00:00:00 -0400</pubDate>
                <guid>https://ir.skyebioscience.comhttps://ir.skyebioscience.com/sec-filings/all-sec-filings/content/0001628280-26-058121/0001628280-26-058121.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[8-K - Current report]]></title>
                <description><![CDATA[8-K]]></description>
                <link>https://ir.skyebioscience.comhttps://ir.skyebioscience.com/sec-filings/all-sec-filings/content/0001628280-26-057804/0001628280-26-057804.pdf</link>
                <pubDate>Wed, 19 Aug 26 00:00:00 -0400</pubDate>
                <guid>https://ir.skyebioscience.comhttps://ir.skyebioscience.com/sec-filings/all-sec-filings/content/0001628280-26-057804/0001628280-26-057804.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material]]></title>
                <description><![CDATA[DEFA14A]]></description>
                <link>https://ir.skyebioscience.comhttps://ir.skyebioscience.com/sec-filings/all-sec-filings/content/0001628280-26-057806/0001628280-26-057806.pdf</link>
                <pubDate>Wed, 19 Aug 26 00:00:00 -0400</pubDate>
                <guid>https://ir.skyebioscience.comhttps://ir.skyebioscience.com/sec-filings/all-sec-filings/content/0001628280-26-057806/0001628280-26-057806.pdf</guid>
                                                                            </item>
            </channel>
</rss>